Financhill
Sell
31

RNA Quote, Financials, Valuation and Earnings

Last price:
$31.71
Seasonality move :
0%
Day range:
$30.33 - $31.88
52-week range:
$21.56 - $56.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
324.66x
P/B ratio:
2.68x
Volume:
1.2M
Avg. volume:
1.3M
1-year change:
33.33%
Market cap:
$3.8B
Revenue:
$10.9M
EPS (TTM):
-$2.89

Earnings Data

Next earnings date for RNA
May 09
2025
Most recent earnings per share
-$0.80
Missed by $0.02
(Feb 27/2025)
Consensus Estimate
-$0.78
(Feb 27/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RNA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/09/2025 Q1 $2.6M -- -- -$0.88 --
02/27/2025 Q4 $1.7M $3M -$0.80 -$0.78 -$0.02
11/07/2024 Q3 $4.6M $2.3M -$0.65 -$0.72 $0.07
08/09/2024 Q2 $3M $2M -$0.65 -$0.78 $0.13
05/09/2024 Q1 $2.6M $3.5M -$0.79 -$0.88 $0.09
02/28/2024 Q4 $12.2M $2.2M -$0.80 -$0.63 -$0.17
11/08/2023 Q3 -- -- -$0.71 -$0.75 $0.04
08/08/2023 Q2 -- -- -$0.66 -$0.79 $0.13
05/09/2023 Q1 -- -- -$0.74 -$0.86 $0.12
02/28/2023 Q4 -- -- -$0.88 -$0.88 $0.00
11/08/2022 Q3 -- -- -$0.82 -$0.94 $0.12
08/09/2022 Q2 -- -- -$0.92 -$0.77 -$0.15
05/10/2022 Q1 -- -- -$0.71 -$0.83 $0.12
03/01/2022 Q4 -- -- -$1.64 -$0.72 -$0.92
11/09/2021 Q3 -- -- -$0.68 -$0.68 -$0.00
08/09/2021 Q2 -- -- -$0.70 -$0.71 $0.01
05/12/2021 Q1 -- -- -$0.64 -$0.56 -$0.08
03/15/2021 Q4 -- -- -$0.43 -$0.34 -$0.09
11/10/2020 Q3 -- -- -$0.31 -$0.44 $0.13
08/10/2020 Q2 -- -- -$1.23 -$0.36 -$0.87
03/31/2020 Q1 -- -- -$0.20 -- --
12/31/2019 Q4 -- -- -$0.50 -- --
09/30/2019 Q3 -- -- -$0.32 -- --
06/30/2019 Q2 -- -- -$0.25 -- --
03/31/2019 Q1 -- -- -$0.12 -- --

Avidity Biosciences Earnings Questions

  • How Much did Avidity Biosciences Generate in Revenue Last Quarter?

    Avidity Biosciences reported $3M worth of top line sales in its most recent quarter.

  • Did Avidity Biosciences Beat Earnings Last Quarter?

    Avidity Biosciences announced earnings per share of -$0.80 which represents a miss of analyst forecast a -$0.78 per share.

  • Is Avidity Biosciences Profitable?

    Avidity Biosciences reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Avidity Biosciences EPS Next Year?

    Avidity Biosciences's earnings are forecast to decrease from -$2.89 per share to -$2.86 per share next year representing a decrease of -35.09%.

  • When is Avidity Biosciences's Earnings Date?

    Avidity Biosciences's next earnings date is May 9, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Shopify a Millionaire Maker?
Is Shopify a Millionaire Maker?

Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…

Is Alphabet Stock No Longer a Good Bet?
Is Alphabet Stock No Longer a Good Bet?

Alphabet tripled its price per share over the past 5…

Pepsi Vs Coke Stock: Which Is Best?
Pepsi Vs Coke Stock: Which Is Best?

Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Sell
50
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 20

Regencell Bioscience Holdings [RGC] is up 15.05% over the past day.

Buy
82
EXOD alert for Mar 20

Exodus Movement [EXOD] is down 0.61% over the past day.

Sell
50
SRPT alert for Mar 20

Sarepta Therapeutics [SRPT] is down 3.84% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock